Dana–Farber Cancer Institute
Dana–Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana–Farber is the founding member of Dana–Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
| Dana–Farber Cancer Institute | |
|---|---|
| Geography | |
| Location | 450 Brookline Avenue, Boston, Massachusetts, United States |
| Coordinates | 42.337637°N 71.108195°W |
| Organization | |
| Care system | Private |
| Funding | Non-profit hospital |
| Type | Specialist |
| Affiliated university | Harvard Medical School, Harvard University |
| Services | |
| Standards | NCI-designated Cancer Center |
| Speciality | Oncology, Teaching hospital |
| Helipad | Yes |
| History | |
| Opened | 1947 |
| Links | |
| Website | www |
| Lists | Hospitals in Massachusetts |
As of 2023, Dana–Farber is ranked the #4 cancer hospital in the world. Two Nobel laureates in Physiology or Medicine are among its past and present faculty. Dana–Farber's research discoveries include the development of the highly successful Gleevec to treat chronic myeloid leukemia.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.